Our previous results showed that B subtilis has antagonized with seven typical nasopharyngeal pathogens in vitro such as Heamophilus influenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes.